COLLABORATION AGREEMENT between PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and GEN-PROBE INCORPORATED Dated as of June 15, 2010Collaboration Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • California
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into between Pacific Biosciences of California, Inc., a Delaware corporation (“PacBio”), having a place of business at 1505 Adams Drive, Menlo Park, California 94025 and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”), having a place of business at 10210 Genetic Center Drive, San Diego, California 92121. PacBio and Gen-Probe may each sometimes be referred to herein as a “party” and collectively as the “parties.”
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Hugh Martin (“Executive”) and Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), effective as of September 16, 2010 (the “Effective Date”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • New York
THIS AGREEMENT is effective as of February 1, 2004 (“Effective Date”) between Nanofluidics, Inc. (“LICENSEE”), a corporation of the State of Delaware, that has a principal place of business at 31 Dutch Mill Road, Ithaca, New York 14850, and Cornell Research Foundation, Inc. (“FOUNDATION”), a non-profit corporation of the State of New York, having an office at 20 Thornwood Drive, Suite 105, Ithaca, NY 14850. FOUNDATION and LICENSEE (individually “Party” and collectively, “Parties”) hereby agree as follows:
LICENSE AGREEMENTLicense Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • New York
THIS LICENSE AGREEMENT (this “Agreement”), dated as of September 11, 2006 (the “Effective Date”), is made by and between GE Healthcare Bio-Sciences Corp., with a principal place of business at 800 Centennial Avenue, Piscataway, New Jersey 08855 (“GEHC”), and Pacific Biosciences of California, Inc., with a principal place of business at 1505 Adams Drive, Menlo Park, CA 94025 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT Between INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION Licensor And NANOFLUIDICS, INC. Licensee *** Confidential Treatment RequestedExclusive License Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • Indiana
Introduction: This Exclusive License Agreement (“Agreement”) is made and entered into on the Effective Date by and between the Indiana University Research and Technology Corporation, a nonprofit corporation organized under the laws of the state of Indiana, having its principal offices at 351 West 10th Street, Indianapolis, Indiana 46202 (hereinafter “IURTC”), and Nanofluidics, Inc., a corporation organized under the laws of the State of Delaware, having its address at 1505 Adams Drive, Menlo Park, CA 94025 (hereinafter “Nanofluidics”).
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2010 • Pacific Biosciences of California Inc • Laboratory analytical instruments • California
This Employment Agreement (the “Agreement”) is entered into as of September 16, 2010 (the “Effective Date”) by and between Pacific Biosciences of California, Inc. (the “Company”) and Hugh Martin (“Executive”).
September 15, 2010Pacific Biosciences of California Inc • September 20th, 2010 • Laboratory analytical instruments
This letter is to confirm the terms of your employment with Pacific Biosciences, Inc. (the “Company”). This letter supersedes all prior agreements relating to the terms of your employment, except for the Change in Control Severance Agreement dated September 9, 2010, between you and the Company (the “Severance Agreement”) and the Pacific Biosciences At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement dated February 22, 2010, between you and the Company (the “Confidentiality Agreement”). This letter reflects the terms that are in effect as of September 15, 2010 (the “Effective Date”).
September 15, 2010Pacific Biosciences of California Inc • September 20th, 2010 • Laboratory analytical instruments
This letter is to confirm the terms of your employment with Pacific Biosciences, Inc. (the “Company”). This letter supersedes all prior agreements relating to the terms of your employment, except for the Change in Control Severance Agreement dated September 9, 2010, between you and the Company (the “Severance Agreement”) and the Proprietary Information and Inventions Agreement dated March 3, 2004, between you and the Company (the “Confidentiality Agreement”). This letter reflects the terms that are in effect as of September 15, 2010 (the “Effective Date”).
September 15, 2010Pacific Biosciences of California Inc • September 20th, 2010 • Laboratory analytical instruments
This letter is to confirm the terms of your employment with Pacific Biosciences, Inc. (the “Company”). This letter supersedes all prior agreements relating to the terms of your employment, except for the Change in Control Severance Agreement dated September 9, 2010, between you and the Company (the “Severance Agreement”) and the At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement dated April 18, 2005, between you and the Company (the “Confidentiality Agreement”). This letter reflects the terms that are in effect as of September 15, 2010 (the “Effective Date”).
